ReviewCancers2021
Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors.
Jim Middelburg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
106 papers cite itlatest 60 shown
this paperpooled itcites it
ReviewCancers2021
Jim Middelburg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.